Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: A protocol for a randomIsed controlled Trial (CAP-IT)
Mark D. Lyttle*, Julia A. Bielicki, Sam Barratt, David Dunn, Adam Finn, Lynda Harper, Pauline Jackson, Colin V.E. Powell, Damian Roland, Wolfgang Stohr, Kate Sturgeon, Mandy Wan, Paul Little, Saul N. Faust, Julie Robotham, Alastair D. Hay, Diana M. Gibb, Mike Sharland
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
9Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: A protocol for a randomIsed controlled Trial (CAP-IT)'. Together they form a unique fingerprint.